Fundraising Fox

Puracath

Silicon Valley, US · Delaware corporation · 4 known investors

PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings. The company targets healthcare providers and patients who use catheters.

Founders & leadership

JRJulia Rasooly
Julia RasoolyCEO

Investors · 4

Reported raises · per SEC filings

Form D private placements

$346K disclosed across 1 round · 2020

$346KraisedJun 2020 · 4 investors · Biotechnology
Officers, directors & promoters on the filing
  • Julia RasoolyExecutive Officer
Offering amount
$346K
Amount sold
$346K
Minimum investment
$199
Sales commissions
$25.9K
Proceeds to insiders
$85K
Placement agents
SI Securities, LLC
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
04
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Puracath for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Puracath do?
PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings. The company targets healthcare providers and patients who use catheters.
Who are Puracath's investors?
Puracath's investors include Cota Capital, Geekdom, Rising Tide, TransPacific Venture Partners.
How much funding has Puracath raised?
Puracath has disclosed $346K raised across 1 round.
Where is Puracath headquartered?
Puracath is headquartered in Silicon Valley, US.